XML 45 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Plans Stock-Based Compensation Plans
We may grant restricted stock units, non-qualified stock options and performance stock units to eligible employees. All stock-based awards are approved by the Executive Compensation Committee of the Board of Directors. We settle stock awards with treasury shares. At December 31, 2021, there were 119,940,056 shares available for future grants.

Restricted Stock Units
Restricted stock units (RSUs) typically vest ratably over a three-year service period and entitle the holder to shares of common stock as the units vest. The following table summarizes information about RSUs:
20212020
SharesWeighted average fair valueSharesWeighted average fair value
Outstanding - beginning of the year6,560,372 $6.27 4,480,847 $9.51 
Granted2,100,126 8.36 4,123,544 3.92 
Vested(2,504,189)6.72 (1,486,371)9.65 
Forfeited(418,016)6.61 (557,648)5.06 
Outstanding - end of the year5,738,293 $6.95 6,560,372 $6.27 

The fair value of RSUs is determined based on the stock price on the grant date less the present value of expected dividends. At December 31, 2021, there was $9 million of unrecognized compensation cost related to RSUs that is expected to be recognized over a weighted-average period of 1.6 years. The intrinsic value of RSUs outstanding at December 31, 2021 was $38 million. The fair value of RSUs vested during 2021, 2020 and 2019 was $22 million, $6 million and $8 million, respectively. During 2019, we granted 3,113,886 RSUs at a weighted average fair value of $6.56.

In 2021 and 2020, we granted 121,455 and 282,131 RSUs, respectively, to non-employee directors. These RSUs vest one year from the grant date.
Performance Stock Units
Performance stock units (PSUs) are stock awards where the number of shares ultimately received by the employee is conditional upon the attainment of certain performance targets and total shareholder return relative to peer companies. PSUs vest at the end of a three-year service period and the actual number of shares awarded may range from 0% to 200% of the target award. The final determination of the number of shares to be issued is made by the Board of Directors, who may reduce, but not increase, the number of shares to be awarded (negative discretion). PSUs are accounted for as variable awards until the end of the service period when the grant date is established.

The following table summarizes share information about PSUs:
20212020
SharesWeighted average fair valueSharesWeighted average fair value
Outstanding - beginning of the year1,730,002 $9.31 2,778,362 $10.09 
Vested(287,109)9.33 (303,460)4.00 
Forfeited(433,802)9.33 (744,900)11.57 
Outstanding - end of the year1,009,091 $6.60 1,730,002 $9.31 

Share-based compensation expense for PSUs is recognized ratably over the service period based on the number shares expected to be awarded and the fair value of an award. The fair value of PSUs is determined using a Monte Carlo simulation model. Due to the variability of these awards, significant fluctuations in share-based compensation expense for PSUs recognized from one period to the next are possible. During 2019, we granted 1,368,182 PSUs at an initial award date fair value of $6.60.

Stock Options
Stock options are granted at an exercise price equal to or greater than the stock price of our common stock on the grant date. Options vest ratably over three years and expire ten years from the grant date. At December 31, 2021, there was $2 million of unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.4 years. The intrinsic value of options outstanding at December 31, 2021 was $7 million and the intrinsic value of options exercisable was not significant.

The following table summarizes information about stock option activity:
20212020
SharesPer share weighted average exercise pricesSharesPer share weighted average exercise prices
Options outstanding - beginning of the year12,814,365 $11.81 12,822,684 $14.08 
Granted737,842 8.48 2,801,982 3.98 
Exercised(777,429)6.11 (33,501)6.82 
Canceled(604,101)11.71 (1,653,126)10.09 
Expired(1,050,608)25.85 (1,123,674)22.09 
Options outstanding - end of the year11,120,069 $10.65 12,814,365 $11.81 
Options exercisable - end of the year8,853,859 $11.94 7,027,974 $16.76 

There were no stock option exercises in 2019.
The following table provides additional information about stock options outstanding and exercisable at December 31, 2021:
Options OutstandingOptions Exercisable
Range of per share exercise pricesSharesPer share weighted-average exercise priceWeighted-average remaining contractual lifeSharesPer share weighted-average exercise priceWeighted-average remaining contractual life
$3.98 - $8.76
5,460,787 $5.65 7.7 years3,194,577 $5.69 7.2 years
$12.64 - $16.88
4,857,128 $14.40 4.5 years4,857,128 $14.40 4.5 years
$17.20 - $23.94
802,154 $21.93 1.2 years802,154 $21.93 1.2 years
11,120,069 $10.64 5.8 years8,853,859 $11.94 5.2 years

The fair value of stock options is determined using a Black-Scholes valuation model and requires assumptions be made regarding the expected stock price volatility, risk-free interest rate, life of the award and dividend yield. The expected stock price volatility is based on historical price changes of our stock. The risk-free interest rate is based on U.S. Treasuries with a term equal to the expected life of the award. The expected life of the award and expected dividend yield are based on historical experience.

The following table lists the weighted average of assumptions used to calculate the fair value of stock options granted:
Years Ended December 31,
202120202019
Expected dividend yield2.4 %5.0 %3.0 %
Expected stock price volatility70.0 %43.0 %41.5 %
Risk-free interest rate1.1 %1.5 %2.5 %
Expected life7 years7 years5 years
Weighted-average fair value per option granted$4.53$1.01$1.98
Fair value of options granted$3,342$2,830$1,722

Employee Stock Purchase Plan (ESPP)
We maintain a non-compensatory ESPP that enables substantially all U.S. and Canadian employees to purchase shares of our common stock at an offering price of 95% of the average market price on the offering date. At no time will the exercise price be less than the lowest price permitted under Section 423 of the Internal Revenue Code. Employees purchased 182,899 shares and 291,540 shares in 2021 and 2020, respectively. We have reserved 1,818,727 common shares for future purchase under the ESPP.